{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Sharm",
      "state": "N/A",
      "country": "United Arab Emirates",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "73420",
      "recalling_firm": "Sun Pharma Global Fze",
      "address_1": "Office # 43 Block Y Saif Zone",
      "address_2": "N/A",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "recall_number": "D-0735-2016",
      "product_description": "Alendronate Sodium Tablets, USP, 70 mg*, 4-count blisters per carton, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India; Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ  08512; NDC 41616-638-68, UPC 3 41616 63868 4.",
      "product_quantity": "381,120 cartons",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: Observed levels of highest unknown impurity exceeding specification limit at the 3 month stability time point.",
      "recall_initiation_date": "20160211",
      "center_classification_date": "20160303",
      "termination_date": "20170523",
      "report_date": "20160309",
      "code_info": "Lot #s: JKP2234A, JKP2235A, Exp 04/17"
    }
  ]
}